Why is Zim Laboratories falling/rising?

As of 19-Sep, Zim Laboratories Ltd is currently priced at 75.79, reflecting a slight increase of 0.01 (0.01%). Despite this minor uptick, the stock has shown significant underperformance, with a 1-week return of -0.01% and a 1-month return of -1.70%. The stock is trading below its longer-term moving averages, specifically lower than the 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the company has experienced a substantial decline in profits, with a year-over-year return of -31.72% and a drop in net sales of -12.3%. While the stock is trading at a discount compared to its peers, the overall weak long-term fundamentals and consistent negative results over the past five quarters contribute to its recent price movement.
In the broader market context, the Sensex has shown a positive return of +0.88% over the past week, contrasting sharply with Zim Laboratories' performance. The stock's liquidity appears adequate, with a delivery volume increase of 44.95% against the 5-day average, yet it still underperformed its sector by -0.26% today. The persistent underperformance against the benchmark over the last three years, coupled with a weak return on capital employed and declining operating profits, suggests that investor sentiment remains cautious. Overall, while there may be some short-term fluctuations, the long-term outlook for Zim Laboratories appears challenging, contributing to its current price dynamics.